| Document |
Document Title |
|
WO/2011/148392A1 |
The present invention relates to a process for the preparation of (2S,4S,5S,7S)-N-(2- Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-
8-[4-methoxy-3-(3-methoxy propoxy )phenyl]-octanamide compound of formula- 1 and its pharm...
|
|
WO/2011/146953A1 |
A compound of formula I wherein PROT is an amine protecting group and PROT' is hydrogen; or PROT and PROT' together with the nitrogen atom to which they are attached form a heterocyclic ring as an amine protecting group, and PROT" is a t...
|
|
WO/2011/145733A1 |
Disclosed is a novel alicyclic epoxy resin which provides a cured article having excellent heat resistance, optical properties, and toughness. The epoxy resin comprises a diolefin compound represented by formula (1) as a starting materia...
|
|
WO/2011/143097A2 |
Catalyst pellets with a high BET surface area can be formed from the compression of a submicron powder into the selected pellet shape, such as using a press that forms the pellet in a die. Catalysts of particular interest comprise a cera...
|
|
WO/2011/136846A1 |
Polycyclopentadiene compounds represented by compounds of the following Formula I: in which each X is either a hydrogen, a cyano group, a vinylbenzyl group, an allyl group, an acrylate group, or a structure of Formula II:; n has an avera...
|
|
WO/2011/136843A1 |
The present disclosure provides for polycyclopentadiene compounds that useful as an epoxide resin and/or as an adduct for a curable composition.
|
|
WO/2011/131543A1 |
The invention relates to a process for the preparation of formula (I), which process comprises a) reacting the compound (II), with cyclopentadiene to (III); b) reacting this compound in the presence of an oxidant to the compound of formu...
|
|
WO/2011/131545A1 |
The invention relates to a process for the preparation of the compound of formula (I), which process comprises a) reacting a compound of formula (II), wherein X is chloro or bromo, with an organometallic species in an inert atmosphere to...
|
|
WO/2011/126834A2 |
Disclosed are thioethers, methods for preparing such thioethers, and curable compositions, such as coating and sealant compositions, that include such thioethers. The thioethers can be the reaction product of (a) an alpha, omega dihalo o...
|
|
WO/2011/122544A1 |
Disclosed is a method for efficiently jointly producing carbonyl fluoride and hexafluoropropylene oxide. Specifically disclosed is a method for producing carbonyl fluoride and hexafluoropropylene oxide wherein a step (a)) for obtaining a...
|
|
WO/2011/118368A1 |
Disclosed is a diepoxy compound represented by formula (1) (in which R1, R2, R3, R4, R5, and R6 each independently represent a hydrogen atom or a C1-3 alkyl group).
|
|
WO/2011/118349A1 |
Disclosed is an epoxy compound comprising highly pure N, N, N', N'-tetraglycidyl-3,4'-diaminodiphenyl ether. The highly pure N, N, N', N'-tetraglycidyl-3,4'-diaminodiphenyl ether is produced by means of an addition reaction step wherein,...
|
|
WO/2011/119217A1 |
A process for preparing propylene oxide by epoxidizing propylene with an oxidant in the presence of a pretreated catalyst; wherein the catalyst comprises an activated titanium silicalite with MFI structure (TS-1) catalyst; and wherein th...
|
|
WO/2011/118823A1 |
The present invention relates to a method of producing propylene oxide. A method of producing propylene oxide, comprising the following steps: a propane-dehydrogenation step (1), wherein propane is dehydrogenated to derive a section incl...
|
|
WO/2011/116180A1 |
A process for preparing a divinylarene dioxide including reacting (a) at least one divinylarene; (b) at least one oxidant, wherein the at least one oxidant is a partially neutralized sulfuromonoperoxoic acid such as partially neutralized...
|
|
WO/2011/113228A1 |
Disclosed is a process for preparing guaiacol glycidyl ether, which comprising the following steps: guaiacol and epichlorohydrin are reacted in the presence of an inorganic alkali aqueous solution and a phase transfer catalyst; thereafte...
|
|
WO/2011/115234A1 |
A method for regenerating a titanosilicate catalyst, comprising a step of mixing a titanosilicate having reduced catalytic ability with a cyclic secondary amine, and a method for producing an oxirane compound, which comprises a step of r...
|
|
WO/2011/096459A1 |
It is intended to provide a production method for producing propylene oxide from propylene, hydrogen and oxygen, with improved reaction rate. The present invention provides a method for producing propylene oxide, comprising a step of rea...
|
|
WO/2011/095294A1 |
The invention relates to a process for the manufacture of an epoxyethyl carboxylate or glycidyl carboxylate, including reacting a vinyl carboxylate or an allyl carboxylate using an oxidant and a water-soluble manganese complex in an aque...
|
|
WO/2011/097642A1 |
The present invention generally relates to methods for performing metathesis reactions, including cross-metathesis reactions. Methods described herein exhibit enhanced activity and stereoselectivity, relative to known methods, and are us...
|
|
WO/2011/083537A1 |
Disclosed is a process for producing a polyglycidyl ether that is represented by general formula (II) and in which the total content of chlorine is reduced, the process being characterized by reacting a polyol represented by general form...
|
|
WO/2011/085201A1 |
The disclosure provides a fumagillol type compound and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of using, e.g. in the treatment of obesity are provided.
|
|
WO/2011/084273A1 |
Provided are aminoalcohol compounds for use as neutralizing agents for paints and coatings. The compounds are of the formula (I): or salt thereof, wherein R1, R2, R3, R4, R5, and n are as defined herein. Also provided are precursors of t...
|
|
WO/2011/078060A1 |
Provided are: a process by which a compound having an allyl ether linkage can be efficiently converted into the corresponding glycidyl ether compound under mild conditions using hydrogen peroxide as the oxidizing agent; and a novel monoa...
|
|
WO/2011/078091A1 |
Provided is a process for producing an epoxy compound efficiently by reacting an organic compound having a carbon-carbon double bond with hydrogen peroxide and acetonitrile. A process for the production of an epoxy compound which compris...
|
|
WO/2011/074508A1 |
The present invention relates to a method for producing propylene oxide, comprising a step of bringing propylene, oxygen and a silver catalyst into contact with each other in the presence of water, wherein the silver catalyst is a cataly...
|
|
WO/2011/074507A1 |
The present invention relates to a method of producing propylene oxide, comprising a step of reacting propylene and oxygen in the presence of a silver catalyst and water, wherein the silver catalyst is a catalyst prepared from (a) metall...
|
|
WO/2011/071961A2 |
A hydrolyzed divinylarene dioxide resin composition including the reaction product of (a) a divinylarene dioxide, and (b) water; a process for making the hydrolyzed divinylarene dioxide resin composition; and a curable hydrolyzed divinyl...
|
|
WO/2011/068209A1 |
Disclosed are: a composition containing an intermediate for a water-soluble monomer, which can be used suitably for the production of a water-soluble poly(alkylene glycol) monomer that has a polymerizable double bond at the terminal, can...
|
|
WO/2011/062608A2 |
The present invention provides one or more embodiments of a process for the epoxidation of an olefin. For the embodiments, the process includes reacting the olefin, with the proviso that the olefin is not propylene, with a hydrogen perox...
|
|
WO/2011/054929A2 |
The invention relates to a method for producing triptolide from a suspension cell culture of Tripterygium sp., to a triptolide-enriched extract obtainable by means of extraction from the culture medium of an in vitro culture of dediffere...
|
|
WO/2011/047530A1 |
Compounds having the structure of general formula I or pharmaceutically acceptable salts thereof which are derivatives of fucoxanthin and fucoxanthol are disclosed. A preparation method of the compound and its use in weight reducing are ...
|
|
WO/2011/041907A1 |
The present invention provides a method for treating a cancer in a subject involving administering to the subject a compound of formula (II) or (II'): wherein R1, R2, R3, R4, R5, R6 and R7 are independently H, OH, alkoxy or alkylcarbonyl...
|
|
WO/2011/043204A1 |
Disclosed is a method for producing a diepoxy compound represented by formula (3) that is characterized by reacting a compound as represented by formula (1) with a compound as represented by formula (2) (wherein X1 represents a halogen a...
|
|
WO/2011/040717A2 |
Disclosed is: a novel, simple and low-cost method for preparing 3-hydroxy-4-(2,4,5-trifluorophenyl)-butyric acid, particularly (3S)-3-hydroxy-4-(2,4,5-trifluorophenyl)-butyric acid, which is used as a key intermediate in the preparation ...
|
|
WO/2011/036628A2 |
The present invention relates to novel sulfoperoxycarboxylic acid compounds, and methods for making and using them. The sulfoperoxycarboxylic compounds of the invention are storage stable, water soluble and have low to no odor. Further, ...
|
|
WO/2011/037100A1 |
Monosodium (2S,3S)-3-[[(1S)-1-isobutoxymethyl-3- methylbutyl]-carbamoyl]oxirane-2-carboxylate represented by formula can be used as a prophylactic or therapeutic agent for periodontal diseases including gum disease and apical periodontitis.
|
|
WO/2011/032476A1 |
A method for preparing levo-betaxolol hydrochloride is provided. The method includes using p-hydroxyl phenyl ethanol as starting material and obtaining the pure levo-betaxolol hydrochloride by selectively esterifying alcoholic hydroxyl, ...
|
|
WO/2011/034114A1 |
The disclosed diepoxy compound is indicated by the formula (1) (wherein R1, R2, R3, and R4 each independently represent a hydrogen atom or an alkyl group having 1-3 carbon atoms, and R5 represents an alkyl group having 2-10 carbon atoms).
|
|
WO/2011/030076A1 |
The invention relates to a method for preparing polyols of formula (I''), R'1 being H or an alkyl group, R" being especially an alkyl group, A1 being an alkylene radical and R3 being especially a group -A2-O-Y´, A2 being an alkylene rad...
|
|
WO/2011/030991A1 |
The present invention relates to a furan-based curable compound derived from carbohydrate biomass, to a solvent-free curable composition, and to a method for preparing same, wherein the furan-based curable compound derived from biomass a...
|
|
WO/2011/027802A1 |
A diepoxy compound represented by formula (1). (In the formula, R1, R2, R3, and R4 each independently represents a hydrogen atom or a C1-3 alkyl.)
|
|
WO/2011/024916A1 |
Disclosed is a cyclic compound represented by formula (1). The compound has high solubility in safe solvents, is highly sensitive, and enables the formation of a good resist pattern shape. Therefore, the compound is useful as a component...
|
|
WO/2011/019061A1 |
In order to provide a method for converting a carbon-carbon double bond in an aryl group of a polyaryl ether compound that is a polyaryl-etherized compound having a plurality of phenolic hydroxyl groups into an efficiently-responding pol...
|
|
WO/2011/017600A2 |
In alternative embodiments the invention provides compositions and methods for ameliorating diseases and conditions having a beta-amyloid component, including Alzheimer's disease (AD), Vascular Dementia (VD), dementia, pre-dementia, Cogn...
|
|
WO/2011/012869A2 |
The present invention provides a continuous process for the epoxidation of an olefinic compound with an oxidant, which process comprises reaction of an olefinic compound with an oxidant in the presence of a catalyst in an apparatus that ...
|
|
WO/2011/010614A1 |
Provided is a method for manufacturing an epoxy compound, said method characterized by the use of hydrogen peroxide to oxidize the double bond in an organic compound containing a carbon-carbon double bond, in the presence of a neutral in...
|
|
WO/2011/007877A1 |
Disclosed are: a method for producing an optically active epoxy compound; a ligand which is used in the method; a complex; a method for producing the ligand; and a method for producing the complex. Specifically disclosed are: a complex w...
|
|
WO/2011/005515A2 |
Compounds, pharmaceutical compositions including the compounds, and methods of preparation and use thereof are disclosed. The compounds are hexafluoro-honokiol analogs. The compounds and compositions can be used to treat and/or prevent a...
|
|
WO/2010/148042A1 |
The invention relates to compounds of formula (I), formula (II), formula (III) and formula (IV),and pharmaceutically acceptable salts thereof for the treatment of cancer, inflammation, auto-immune diseases, diabetes and diabetic complica...
|
